Influence of 4‐week or 12‐week glucocorticoid treatment on metabolic changes in patients with active moderate‐to‐severe thyroid‐associated ophthalmopathy

Thyroid‐associated ophthalmopathy (TAO) is a serious, progressive, vision‐threatening and difficult‐to‐treat organ‐specific autoimmune disease. The course, therapeutic effects and prognosis of moderate to severe TAO vary greatly. High‐dose intravenous glucocorticoid (IVGC) therapy is considered a fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoman, Abudukerimu, Buatikamu, Li, Qin, Li, Qing, Qiao, Jie, Lin, Dongping, Sui, Chunhua, Ye, Lin, Zhai, Hualing, Jiang, Boren, Wang, Ningjian, Jiang, Mengda, Tao, Xiaofeng, Shao, Ziyang, Zhu, Chenfang, Ma, Yubo, Xiong, Ping, Sun, Jing, Zhou, Huifang, Han, Bing, Lu, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504830/
https://www.ncbi.nlm.nih.gov/pubmed/33742766
http://dx.doi.org/10.1111/cts.12999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504830/
https://www.ncbi.nlm.nih.gov/pubmed/33742766
http://dx.doi.org/10.1111/cts.12999

Ejemplares similares